Header Logo

Connection

RADEK SKODA to Piperazines

Back to Details
This is a "connection" page, showing publications RADEK SKODA has written about Piperazines.
RADEK SKODA
Connection Strength
0.031
Piperazines
  1. Ruxolitinib-induced defects in DNA repair cause sensitivity to PARP inhibitors in myeloproliferative neoplasms. Blood. 2017 12 28; 130(26):2848-2859.
    View in: PubMed
    Score: 0.031
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.